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1. Data {#sec1}
=======

This dataset contains 1) the construction of engineered *Saccharomyces cerevisiae* strain (YE9) capable of fermenting galacturonic acid, arabionse, and xylose, and 2) its fermentation data with different carbon sources (galacturonic acid, arabinose, xylose, galactose, glucose, and fructose) and their mixtures, all of which present in pectin-rich biomass. In [Fig. 1](#fig1){ref-type="fig"}, the fermentation patterns of the YE9 strain with natively fermentable sugars (glucose, fructose, and galactose) as a sole carbon source are presented. In [Table 1](#tbl1){ref-type="table"}, the fermentation profiles of the YE9 strain with xylose, arabinose, and galacturonic acid in comparison to its wild type strain (D452-2). In [Fig. 2](#fig2){ref-type="fig"}, the YE9 strain was tested for xylose and galacturonic acid consumption rates in a mixture of 40 g/L xylose and various galactornic acid concentrations. In [Table 2](#tbl2){ref-type="table"}, the fermentation parameters of the YE9 strain with a mixture of galacturonic acid and co-substrates.Fig. 1Fermentation profiles of the YE9 strain in a complex medium containing (A) 40 g/L [d]{.smallcaps}-glucose, (B) 40 g/L [d]{.smallcaps}-fructose, and (C) 40 g/L [d]{.smallcaps}-galactose as the sole carbon sources. Fermentations were performed under oxygen-limited conditions (130 rpm) with a starting cell density of 25 g/L. All experiments were performed in biological triplicate, and the error bars indicate the standard deviations.Fig. 1Table 1Fermentation profiles of the native *S. cerevisiae* strain (D452-2) and engineered strain (YE9) expressing heterologous pathways for metabolizing [d]{.smallcaps}-xylose, [l]{.smallcaps}-arabinose, and [d]{.smallcaps}-galacturonic acid (galUA).Table 1StrainSubstrateSubstrate consumed (g/L)Substrate consumption rate (g/L/h)Products (g/L)Parameters[b)](#tbl1fnb){ref-type="table-fn"}GlycerolEthanol*Y*~Glycerol~*Y*~Ethanol~*P*~Ethanol~∗D452-2D-xylose[a)](#tbl1fna){ref-type="table-fn"}5.9 ± 0.20.19 ± 0.010.3 ± 0.0*n. d.*0.07 ± 0.02*n. d.n. d.*[l]{.smallcaps}-arabinose1.3 ± 0.60.08 ± 0.03*n. d.n. d.n. d.n. d.n. d.*galUA\< 0.0\< 0.00*n. d.n. d.n. d.n. d.n. d.*YE9[d]{.smallcaps}-xylose33.7 ± 0.51.41 ± 0.020.6 ± 0.111.3 ± 0.10.02 ± 0.000.34 ± 0.010.05 ± 0.00[l]{.smallcaps}-arabinose30.2 ± 0.10.63 ± 0.07*n. d.*1.9 ± 0.1*n. d.*0.07 ± 0.00\<0.00galUA6.7 ± 0.70.27 ± 0.010.3 ± 0.10.3 ± 0.00.04 ± 0.010.08 ± 0.02\< 0.00[^1][^2]Fig. 2Effect of [d]{.smallcaps}-galacturonic acid on the rate of [d]{.smallcaps}-xylose consumption in the YE9 strain. Consumption rate of [d]{.smallcaps}-xylose (A) and [d]{.smallcaps}-galacturonic acid (B) was evaluated under 40 g/L D-xylose and different [d]{.smallcaps}-galacturonic acid concentrations (0--100 g/L). All experiments were performed in biological triplicate, and error bars indicate standard deviations and were not visible when smaller than the symbol size.Fig. 2Table 2Fermentation profiles of mixed culture by engineered *S. cerevisiae* YE9 strain expressing heterologous pathways metabolizing [d]{.smallcaps}-xylose, [l]{.smallcaps}-arabinose, and [d]{.smallcaps}-galacturonic acid (galUA).Table 2Medium[a)](#tbl2fna){ref-type="table-fn"}Substrate consumed (g/L)galUA consumption rate (g/L/h)Products (g/L)Parameters[b)](#tbl2fnb){ref-type="table-fn"}galUASugarsGlycerolEthanol*Y*~Glycerol~*Y*~Ethanol~*P*~Glycerol~∗*P*~Ethanol~∗galUA6.7 ± 0.7--0.27 ± 0.010.3 ± 0.10.3 ± 0.00.04 ± 0.010.08 ± 0.02\< 0.00\< 0.00galUA + Glucose3.3 ± 0.236.7 ± 0.10.14 ± 0.012.4 ± 0.316.9 ± 0.20.06 ± 0.010.40 ± 0.010.06 ± 0.000.66 ± 0.01galUA + Fructose4.5 ± 0.336.1 ± 0.80.18 ± 0.022.9 ± 0.116.9 ± 0.50.07 ± 0.000.36 ± 0.01\< 0.000.65 ± 0.03galUA + Galactose4.6 ± 1.225.4 ± 7.30.17 ± 0.031.6 ± 0.72.4 ± 1.10.04 ± 0.010.05 ± 0.02\< 0.00\< 0.00galUA+ Xylose13.1 ± 0.433.3 ± 0.50.49 ± 0.024.5 ± 0.112.8 ± 0.30.08 ± 0.000.23 ± 0.010.01 ± 0.000.04 ± 0.00galUA+ Arabinose11.9 ± 0.728.4 ± 0.10.32 ± 0.034.2 ± 0.24.1 ± 0.50.11 ± 0.010.11 ± 0.02\< 0.00\< 0.00galUA\
+Xylose (X)\
+Arabinose (A)15.3 ± 0.633.7 ± 0.1 (X)\
25.9 ± 4.4 (A)0.49 ± 0.045.3 ± 0.616.5 ± 1.20.07 ± 0.000.22 ± 0.01\< 0.000.02 ± 0.00[^3][^4]

2. Experimental design, materials, and methods {#sec2}
==============================================

2.1. Strain construction by Cas9-based genome editing {#sec2.1}
-----------------------------------------------------

To construct the YE9 strain, four consecutive transformations were performed as summarized in [Fig. 3](#fig3){ref-type="fig"} using strains listed in [Table 3](#tbl3){ref-type="table"}. Briefly, the strain construction includes three parts: 1) guide RNA (gRNA) plasmid construction, 2) donor DNA preparation, and 3) yeast transformation.1)Guide RNA (gRNA) plasmid constructionFig.3Construction of engineered *S. cerevisiae* YE9 strains expressing heterologous [d]{.smallcaps}-xylose, [d]{.smallcaps}-galacturonic acid, and [l]{.smallcaps}-arabinose pathways. (A) Strain construction using Cas9-based *in vivo* assembly and genome integration strategy. (B) Confirmation primers for correct assembly and integration by yeast colony PCR. The primer sequences are listed in [Table S5](#appsec1){ref-type="sec"}.Fig.3Table 3*Saccharomyces cerevisiae* strains used for the construction of YE9.Table 3StrainsDescription/relevant genotype[a](#tbl3fna){ref-type="table-fn"}Ref.D452-2Wild type; *Matα leu2 his3 ura3*\[[@bib7]\]DY02Expressing the heterologous [d]{.smallcaps}-xylose pathway;\
D452-2 *ald6::TDH3*~P~*-XYL1-TDH3*~T~*-PGK1*~P~*-XYL2-PGK1*~T~*pho13::TEF1*~P~*-XYL3-TEF1*~T~YE3DY02 *int\#4::CCW12*~P~*-gaaA-CCW12*~T~YE4DY02 *int\#4::PGK1*~P~*-lgd1-PGK1*~T~YE5DY02 *int\#4::TDH3*~P~*-gaaC-TDH3*~T~YE6Expressing the heterologous D-xylose and [d]{.smallcaps}-galacturonic acid pathway;\
DY02 *int\#4::CCW12*~P~*-gaaA-CCW12*~T~*-PGK1*~P~*-lgd1-PGK1*~T~*-TDH3*~P~*-gaaC-TDH3*~T~YE6 *YPR1*YE6 *CCW12*~P~*-YPR1*YE6 *gaaD*YE6 *int\#6::CCW12*~P~*-gaaD-CCW12*~T~YE01Expressing the heterologous [d]{.smallcaps}-xylose, and [l]{.smallcaps}-arabinose pathway;\
D452-2 *ald6::TDH3*~P~*-XYL1-TDH3*~T~*-PGK1*~P~*-XYL2-PGK1*~T~*int\#1::TEF1*~P~*-XYL3-TEF1*~T~*sor1::FBA1*~P~*-LAD1-FBA1*~T~*-PGK1*~P~*-ALX1-CYC1*~T~\[[@bib8]\]YE9Expressing the heterologous [d]{.smallcaps}-xylose, [l]{.smallcaps}-arabinose, and [d]{.smallcaps}-galacturonic acid pathway;YE6 *int\#7::FBA1*~P~*-lad1-FBA1*~T~-*PGK1*~P~*-alx1-CYC1*~T~[^5]

gRNA sequences are designed to be target cut site-specific and 20-bp long, as listed in [Table 4](#tbl4){ref-type="table"}. The plasmids expressing each gRNA sequence were constructed by the fast cloning method \[[@bib2]\], which is a PCR-based protocol for plasmid mutagenesis. To construct the pRS42H-ALD6.1 plasmid, for example, the pRS42H-GND1.1 plasmid (a template plasmid) \[[@bib3]\] was amplified with the primers Kim044/Kim045 ([Table 5](#tbl5){ref-type="table"}). The PCR products were treated with *Dpn*I and used to transform *E. coli* TOP10 (Invitrogen, Carlsbad, CA, USA). The transformants were selected on an LBA (5 g/L yeast extract, 10 g/L tryptone, 10 g/L NaCl, and 100 μg/mL ampicillin) agar plate. The gRNA sequence of the resulting plasmid was confirmed by Sanger sequencing using a universal primer for the T3 promoter. All other gRNA plasmids were constructed using the same procedure but different primers, as listed in [Table 5](#tbl5){ref-type="table"}.2)Donor DNA preparationTable 4Guide RNA (gRNA) plasmids.Table 4gRNATarget cut sitegRNA and PAM sequences (5'-)Plasmid nameALD6.1*ALD6*GTCAAGATCACACTTCCAAA TGGpRS42H-ALD6.1PHO13.1*PHO13*TCCCTTATCTATTAACTTTC CGGpRS42H-PHO13.1YPR1.1*YPR1*CATGGTAGATTATTATCTGT GGGpRS42H-YPR1.1INT\#4Intergenic region upstream *ASF1*CTCTCGAAGTGGTCACGTGC GGGpRS42H-INT\#4INT\#6Intergenic region upstream *ATG33*TTGTCACAGTGTCACATCAG CGGpRS42H-INT\#6INT\#7Intergenic region downstream *YGR190C*GATACTTATCATTAAGAAAA TGGpRS42H-INT\#7Table 5Primers used for construction of guide RNA plasmids.Table 5Plasmid namePrimersSequences (5'-)pRS42H-ALD6.1Kim044[AAGATCACACTTCCAAA]{.ul}GTTTTAGAGCTAGAAATAGCAAGKim045[TTGGAAGTGTGATCTTGAC]{.ul}GATCATTTATCTTTCACTGCGpRS42H-PHO13.1Kim624[CTTATCTATTAACTTTC]{.ul}GTTTTAGAGCTAGAAATAGCAAGKim625[AAAGTTAATAGATAAGGG]{.ul}AGATCATTTATCTTTCACTGCGpRS42H-YPR1.1Kim535[GGTAGATTATTATCTGT]{.ul}GTTTTAGAGCTAGAAATAGCAAGKim536[CAGATAATAATCTACCATG]{.ul}GATCATTTATCTTTCACTGCGpRS42H-INT\#4Kim310[TCGAAGTGGTCACGTGC]{.ul}GTTTTAGAGCTAGAAATAGCAAGKim311[CACGTGACCACTTCGAGAG]{.ul}GATCATTTATCTTTCACTGCGpRS42H-INT\#6Kim314[TCACAGTGTCACATCAG]{.ul}GTTTTAGAGCTAGAAATAGCAAGKim315[TGATGTGACACTGTGACAA]{.ul}GATCATTTATCTTTCACTGCGpRS42H-INT\#7Kim486[AGGAATTATGTTCGCCC]{.ul}GTTTTAGAGCTAGAAATAGCAAGKim487[GGCGAACATAATTCCTTAC]{.ul}GATCATTTATCTTTCACTGCG

Donor DNA fragments were prepared by PCR using the primers listed in [Table 6](#tbl6){ref-type="table"}. Each of the fragments was flanked by 40--50 bp to allow *in vivo* assembly and genome integration through homologous recombination. Each assembly was an expression cassette of a heterologous gene as described in [Fig. 3A](#fig3){ref-type="fig"}. The donor DNAs for the xylose expression cassettes were designed to achieve complete removal of a target gene when genome integrated. On the other hand, the expression cassettes of the arabinose pathway and galacturonic acid pathway were integrated into an intergenic region without interfering neighboring genes.3)Yeast transformationTable 6Primers used for construction of donor DNA fragments.Table 6Template genomic DNA[a](#tbl6fna){ref-type="table-fn"}Donor DNA fragmentsPrimersSequences (5'-)***XYL1* and *XYL2* expression cassettes for deleting *ALD6* (*ald6::TDH3***~**P**~***-XYL1-TDH3***~**T**~***-PGK1***~**P**~***-XYL2-PGK1***~**T**~**)***S. cerevisiaeTDH3*~P~Kim626[TAACATACACAAACACATACTATCAGAATACA]{.ul}CTATTTTCGAGGACCTTGTCSOO384[TCAACTTAATAGAAGGCATTTTTAGATCTCCTAGGTTTGTTTGTTTATGTGTGTTTAT]{.ul} TC*P. stipitisXYL1*SOO385[ATAAACACACATAAACAAACAAACCTAGGAGATCTAAAAATGCCTTCTATTAAGTTGA]{.ul} ACSOO386AAT [GCAAGATTTAAAGTAAATTCACTGTTAACGCATGCTTAGACGAAGATAGGAATCTTG]{.ul}*S. cerevisiaeTDH3*~T~SOO387GGA [CAAGATTCCTATCTTCGTCTAAGCATGCGTTAACAGTGAATTTACTTTAAATCTTGC]{.ul}SOO388ATTCTTTGAAGGTACTT [CTTCGAAAAATTCGCGTCTGCTAGCTCCTGGCGGAAAAAATTC]{.ul}*S. cerevisiaePGK1*~P~SOO389TTTTAAAGTTTACAAAT [GAATTTTTTCCGCCAGGAGCTAGCAGACGCGAATTTTTCGAAG]{.ul}SOO390CACCAA [GGAAGGGTTAGCAGTCATTTTTTCTAGATGTTTTATATTTGTTGTAAAAAGTAG]{.ul}*P. stipitisXYL2*SOO391AATTAT [CTACTTTTTACAACAAATATAAAACATCTAGAAAAAATGACTGCTAACCCTTCC]{.ul}SOO392AAAAAATTGAT [CTATCGATTTCAATTCAATTCAATACTAGTTTACTCAGGGCCGTCAATG]{.ul}*S. cerevisiaePGK1*~T~SOO393GTCAAGTGTCT [CATTGACGGCCCTGAGTAAACTAGTATTGAATTGAATTGAAATCGATAG]{.ul}Kim627[GTATATGACGGAAAGAAATGCAGGTTGGTACA]{.ul} AAATAATATCCTTCTCGAAAG***XYL3* expression cassette for deleting *PHO13* (*pho13::TDH3***~**P**~***-XYL1-TDH3***~**T**~***-PGK1***~**P**~***-XYL2-PGK1***~**T**~**)***S. cerevisiaeTDH3*~P~Kim628[ATGTGACATCTTTACTATTCTCCAGCACGTTT]{.ul} CTTCATCGGTATCTTCGCSOO374AA [TGGGGTAGTGGTCATTTTTAAGCTTGAATTCTTTGTAATTAAAACTTAGATTAGATTG]{.ul}*P. stipitisXYL3*SOO375AT [CTAATCTAAGTTTTAATTACAAAGAATTCAAGCTTAAAAATGACCACTACCCCATTTG]{.ul}SOO376GCAACTA [GAAAAGTCTTATCAATCTCCGTCGACATCGATTTAGTGTTTCAATTCACTTTC]{.ul}*S. cerevisiaeTDH3*~T~SOO377CAAGATG [GAAAGTGAATTGAAACACTAAATCGATGTCGACGGAGATTGATAAGACTTTTC]{.ul}Kim629[CTATAACTCATTATTGGTTAAGGTGTAGATG]{.ul} AAGTTGGGTAACGCCAGG***gaaA* expression cassette (*int\#4::CCW12***~**P**~***-gaaA-CCW12***~**T**~**)***S. cerevisiaeCCW12*~P~Kim379[TTCCTCGGGCAGAGAAACTCGCAGGCAACTTG]{.ul} CACGCAAAAGAAAACCTTKim380TCAACA [CAGCTGGGGGAGCCATTTTTTATTGATATAGTGTTTAAGCGAAT]{.ul}*A. nigergaaA*Kim381TCTGTC [ATTCGCTTAAACACTATATCAATAAAAAATGGCTCCCCCAGCTG]{.ul}Kim382TAGA [ATGTATAAATAATAATAAACTAAGTCTACTTCAGCTCCCACTTTCC]{.ul}*S. cerevisiaeCCW12*~T~Kim383GGAT [GGAAAGTGGGAGCTGAAGTAGACTTAGTTTATTATTATTTATACAT]{.ul}Kim384[TGTGAGGGCCGATTATGCAGGCCTAGA]{.ul} TGTTCTAGTGTGTTTATATTATC***lgd1* expression cassette (*int\#4::PGK1***~**P**~***-lgd1-PGK1***~**T**~**)***S. cerevisiaePGK1*~P~Kim385[CCTCGGGCAGAGAAACTCGCAGGCAACTTG]{.ul} GTGAGTAAGGAAAGAGTGAGKim386[GTGATGGTGACTTCAGACATTTTTTGTTTTATATTTGTTGTAAAAAGTAG]{.ul}*T. reeseilgd1*Kim387[CTACTTTTTACAACAAATATAAAACAAAAAATGTCTGAAGTCACCATCAC]{.ul}Kim388ATTGATCTAT [CGATTTCAATTCAATTCAATTCAGATCTTCTCTCCGTTCA]{.ul}*S. cerevisiaePGK1*~T~Kim389CTGCCCATCT [TGAACGGAGAGAAGATCTGAATTGAATTGAATTGAAATCG]{.ul}Kim390[CTCTGTGAGGGCCGATTATGCAGGCCTAGA]{.ul} AAATAATATCCTTCTCGAAA***gaaC* expression cassette (*int\#4::TDH3***~**P**~***-gaaC-TDH3***~**T**~**)***S. cerevisiaeTDH3*~P~Kim391[CTCGGGCAGAGAAACTCGCAGGCAACTTG]{.ul} GAATAAAAAACACGCTTTTTCKim392GACTCCGGGGCG [GAGCGGGGTAAAAGGCATTTTTTTTGTTTGTTTATGTGTGTT]{.ul}*A. nigergaaC*Kim393TTCGAATA [AACACACATAAACAAACAAAAAAAATGCCTTTTACCCCGCTC]{.ul}Kim394ATTTAAAT [GCAAGATTTAAAGTAAATTCACCTAAGCAATATCCGGCAACG]{.ul}*S. cerevisiaeTDH3*~T~Kim395TGAGAAGT [CGTTGCCGGATATTGCTTAGGTGAATTTACTTTAAATCTTGC]{.ul}Kim396[CCTCTGTGAGGGCCGATTATGCAGGCCTAGA]{.ul} ATCCTGGCGGAAAAAATTC***gaaA*, *lgd1*, and *gaaC* expression cassettes (*int\#4::CCW12***~**P**~***-gaaA-CCW12***~**T**~***-PGK1***~**P**~***-lgd1-PGK1***~**T**~***-TDH3***~**P**~***-gaaC-TDH3***~**T**~**)***S. cerevisiae* YE3*CCW12*~P~*-gaaA-CCW12*~T~Kim410[TCTTTAGGTTAATTGTCGCTGTTATTGTCTA]{.ul} GATTTTTTCTCGGAGATGGKim411TAGTTC [CTCACTCTTTCCTTACTCACTGTTCTAGTGTGTTTATATTATCC]{.ul}*S. cerevisiae* YE4*PGK1*~P~*-lgd1-PGK1*~T~Kim412AGCCAA [GGATAATATAAACACACTAGAACA GTGAGTAAGGAAAGAGTGAG]{.ul}Kim413AAACTCGAA [CTGAAAAAGCGTGTTTTTTATTCCCGATTATGCAGGCCTAG]{.ul}*S. cerevisiae* YE5*TDH3*~P~*-gaaC-TDH3*~T~Kim414TATTATTTT [CTAGGCCTGCATAATCGGGAATAAAAAACACGCTTTTTCAG]{.ul}Kim415[CTACTCTCTTCCTAGTCGCCCGGTTGTT]{.ul} GAAAGTTTAATTGTGGGTTTTC***lad1 and alx1* expression cassettes (*int\#7::FBA1***~**P**~***-lad1-FBA1***~**T**~**-*PGK1***~**P**~***-alx1-CYC1***~**T**~**)***S. cerevisiae* YE01*FBA1*~P~*-lad1-FBA1*~T~-*PGK1*~P~*-alx1-CYC1*~T~Kim553[CTTACACTTGTGTAATGACAAATGTTTTT]{.ul} TGAACAACAATACCAGCCTTCKim554[TGTTTCACGTTATCAAGATTATGTCATCTATT]{.ul} GGCCGCAAATTAAAGCCT**Overexpression of *YPR1* (*CCW12***~**P**~***-YPR1*)***S. cerevisiaeCCW12*~P~Kim537[GTAACTTTGCAATATAATCAGGTCGCAAATAT]{.ul} CACGCAAAAGAAAACCTTKim538[GAAGAATTCTTTAACGTAGCAGGCAT]{.ul} TATTGATATAGTGTTTAAGCGAAT***gaaD* expression cassette (*int\#6::CCW12***~**P**~***-gaaD-CCW12***~**T**~**)***S. cerevisiaeCCW12*~P~Kim541[CGGAGGAGACCGCTATAACCGGTTTGAATTTA]{.ul} CACGCAAAAGAAAACCTTKim542TA [ACCTTCTTTCCGAGAGACATTTTTTATTGATATAGTGTTTAAGCGAAT]{.ul}*A. nigergaaD*Kim543TC [ATTCGCTTAAACACTATATCAATAAAAAATGTCTCTCGGAAAGAAGGT]{.ul}Kim544GT [ATAAATAATAATAAACTAAGTTTATTAAACAATCACCTTATGACCAGC]{.ul}*S. cerevisiaeCCW12*~T~Kim545TG [GTCATAAGGTGATTGTTTAATAAACTTAGTTTATTATTATTTATACAT]{.ul}Kim546[CTTGCTTGCTGTCAAACTTCTGAGTTG]{.ul} TGTTCTAGTGTGTTTATATTATC[^6][^7]

For yeast transformation, a gRNA plasmid (4 μg) and donor DNA fragments (4 μg each) were used to transform a designated strain harboring pRS41N-Cas9 \[[@bib3]\]. The resulting transformants were selected on a YPD agar plate supplemented with 100 μg/mL nourseothricin sulfate (Gold Biotechnology, St. Louis, MO, USA) and 300 μg/mL hygromycin B (Invitrogen, Carlsbad, CA, USA). Selected transformants were serially sub-cultured in YPD medium supplemented with 100 μg/mL nourseothricin sulfate to only remove the existing gRNA plasmids. Correct assembly and integration was then confirmed by yeast colony PCR with the primers listed in [Table 7](#tbl7){ref-type="table"}. Through four consecutive transformations, as described in [Fig. 3](#fig3){ref-type="fig"}, the YE9 strain was finally constructed.Table 7Primers used for confirmation of correct assembly and integration.Table 7PrimersSequences (5'-)PrimersSequences (5'-)Introduction of [d]{.smallcaps}-xylose pathwayIntroduction of [d]{.smallcaps}-galacturonic acid pathwayKim049GGAACGGTGAGTGCAACGKim322GCGCATCTATTTGCCGTCKim427AAACTGTTCACCCAGACACCKim397GCTGGGGGAGCCATTTTTTATTGKim194AGCGCAACTACAGAGAACAGGKim398GTGGGAGCTGAAGTAGACTTAGKim100CGGCACCGTCGAACAATCTGKim323TCACGACACACCTCACTGKim101CCGCTTACTCTTCGTTCGGTCCKim399CCTGTGATGGTGACTTCAGACKim193CTCAGCATCCACAATGTATCAGKim401GAACGGAGAGAAGATCTGAATTGKim426GCGCTATTGCATTGTTCTTGTCKim400ACAGCCTGTTCTCACACACKim547AGGTATGCGATAGTTCCTCACKim402GCGGGGTAAAAGGCATTTTTTTTGKim125TGCAGCTTCCAATTTCGTCACKim408GCCGGATATTGCTTAGGTGKim630GAGGTGACACCCTTACCAACKim631CTGCTACTCACACCTTCAACTC**Introduction of [l]{.smallcaps}-arabinose pathway**Kim632CGCTGAACCCGAACATAGAAATATCKim490GGCACTAGGAGCATTTGTCGKim633TCGATATTTCTATGTTCGGGTTCAGKim304GCTTCGCTAATCCAGAGGTCKim078GATTGGAATTGGTTCGCAGTGKim400ACAGCCTGTTCTCACACACKim048GAGGAAGACGTTGAAGGTGGKim491GTCCCTTAGGGTGCGTATAATGKim149TTTGAAGTGGTACGGCGATGKim577CACCCAAGCACAGCATAC**Overexpression of *YPR1***Kim634TGGCTCGATAACGAAGATTCAGKim539CAATTCCGTGAAACCCTTTTCTTKim635GTCTTGTAGATTGAGAACTGGTCCKim540CTGCCAACTTCTTCTTCATTCAAKim636TCTATGAGGCAAGTAAGAGGCACKim492AACAGGCGACAGTCCAAATG**Introduction of *gaaD* gene cassette**Kim077TTGGAGTTCAAACTGGCGAGKim326GGTTCTGACTCCTACTGAGCKim093GCAAAGATAGCGGCGTAGGTGKim549GCATCCTTTGCCTCCGTTCKim327AGCATCGAGTACGGCAGTTC

2.2. Fermentation {#sec2.2}
-----------------

For fermentation of the YE9 strain, one colony was pre-cultured in YP medium (10 g/L yeast extract and 20 g/L peptone) supplemented with 20 g/L of glucose for 36 h at 30^o^C and 250 rpm. Cells were centrifuged, washed twice, and re-suspended in YP medium supplemented with desired carbon sources. The initial cell density of fermentation was 25 g/L dry weight, which corresponds to approximately 125 g/L wet weight, and this conversion factor was obtained from a prior study \[[@bib4]\]. In the industrial bioethanol processes, \>90% cells are recycled in repeated batch-type fermentation; therefore, very high cell density of up to 170 g/L wet weight \[[@bib5]\] is often achieved. The concentrations of the carbon sources were selected to reflect the typical chemical composition of pectin-rich biomass ([Table 8](#tbl8){ref-type="table"}).Table 8Chemical composition of pectin-rich biomass.Table 8SourceArabinoseGalacturonic acidRatioReferenceOrange peel hydrolysate (g/L, ∼ 10% solid loading)32.613.22.47\[[@bib9]\]Sugar beet pulp hydrolysate (g/100 g dry matter)22.522.51.00\[[@bib10]\]

2.3. HPLC analysis {#sec2.3}
------------------

Quantitation of glucose, fructose, galactose, xylose, arabinose, galacturonic acid, glycerol, and ethanol was performed by high-performance liquid chromatography (HPLC; Agilent Technologies, 1260 series, USA) device equipped with a RI detector and a Rezex-ROA Organic Acid H+ (8%) (150 mm × 4.6 mm) column (Phenomenex Inc., Torrance, CA, USA). The column was eluted with 0.005 N H~2~SO~4~ at 0.6 mL/min and 50^o^C \[[@bib1],[@bib6]\].
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[^1]: Fermentations were performed in a complex medium containing 40 g/L [d]{.smallcaps}-xylose, 40 g/L [l]{.smallcaps}-arabinose, or 20 g/L [d]{.smallcaps}-galacturonic acid under oxygen-limited conditions (130 rpm) with a starting cell density of 25 g/L. Substrate consumption rate was calculated for 24 h and the others were calculated for 72 h.

[^2]: *Y*~Glycerol~, glycerol yield (g glycerol/g substrate); *Y*~Ethanol~, ethanol yield (g ethanol/g substrate); *P*~Ethanol~∗, specific ethanol productivity (g ethanol/g cell/h); *n. d*., not detected.

[^3]: Fermentations were performed in a complex medium containing 20 g/L [d]{.smallcaps}-galacturonic acid (galUA) and 40 g/L sugar ([d]{.smallcaps}-glucose, [d]{.smallcaps}-fructose, [d]{.smallcaps}-galactose, [d]{.smallcaps}-xylose, [l]{.smallcaps}-arabinose, and mixture of [d]{.smallcaps}-xylose and [l]{.smallcaps}-arabinose) under oxygen-limited conditions (130 rpm) with a starting cell density of 25 g/L. [d]{.smallcaps}-galacturonic acid consumption rate was calculated for 24 h and the others were calculated for 72 h.

[^4]: *Y*~Glycerol~, glycerol yield (g glycerol/g substrates); *Y*~Ethanol~, ethanol yield (g ethanol/g substrates); *P*~Glycerol~∗, specific glycerol productivity (g glycerol/g cell/h); *P*~Ethanol~∗, specific ethanol productivity (g ethanol/g cell/h).

[^5]: *XYL1*, *XYL2*, and *XYL3* are derived from *Pichia stipitis*; *gaaA*, *gaaC*, and *gaaD* are derived from *Aspergillus niger*; *lgd1* and *lad1* are derived from *Trichoderma reesei*; *alx1* is derived from *Ambrosiozyma monospora*.

[^6]: The flanking region is underlined.

[^7]: *Saccharomyces cerevisiae* D452-2; *Pichia stipitis* CBS 6054; *Aspergillus niger* CBS 120.49; *Trichoderma reesei* ATCC 5676.
